life expectancy pulmonary hypertension

The life expectancy of individuals with pulmonary arterial hypertension (PAH) can vary significantly based on personal factors. Generally, those who receive a timely diagnosis and appropriate treatment may have a lifespan that is close to that of the general population.

A multitude of factors can influence the life expectancy of PAH patients, including the severity of their disease, the presence of complications, age, gender, and their response to therapy. Typically, patients with milder forms of the disease and without significant complications tend to have a longer life expectancy. However, as the disease progresses, especially with the onset of severe complications like heart failure, the life expectancy of patients can be considerably reduced. Moreover, older patients and those of certain genders, such as females, may be at an increased risk.

For individuals suffering from PAH, it is advised to have regular medical check-ups, closely monitor any changes in their condition, and adhere to the treatment regimen prescribed by their physician. Self-adjustment of medication dosage or discontinuation of medication is strongly discouraged to prevent exacerbation of the disease. Additionally, maintaining a healthy lifestyle, including smoking cessation, moderate alcohol consumption, regular physical activity, and a positive mental state, can contribute to improving quality of life and potentially extending life expectancy. Should any concerns or discomforts arise, it is crucial to consult with a healthcare professional promptly.